Veerhealth's annual revenue nearly doubles to ₹32.5 cr, but Q4 flips to a loss
The personal-care contract manufacturer's full-year profit rose 39% to ₹54.4 lakhs, but a ₹31 lakh one-off charge sank the final quarter into the red.
— 1 earlier story on Veerhealth Care Ltd. →What's new
- Full-year revenue jumped 93% to ₹32.48 crore; net profit rose 39% to ₹54.40 lakhs.
- Q4 revenue of ₹16.76 crore was nearly triple the prior-year quarter, but net loss was ₹35.37 lakhs.
- The Q4 loss followed a ₹31 lakh exceptional charge and a deferred tax provision.
Why this matters
Veerhealth's annual results show the top-line is scaling fast, nearly doubling on the back of recent order wins. The Q4 loss, however, is a one-off hit from an exceptional charge, not an operational miss. The auditors' clean opinion and the decision to skip a dividend to reinvest signal a company in a growth phase, not a crisis.
What we're watching
- Whether the strong revenue momentum from order wins carries into FY27.
- If the exceptional charge was a one-time write-off or related to a recurring issue.
- How the company deploys the cash it chose to retain by skipping the dividend.
The full read
Veerhealth Care's revenue nearly doubled in FY26 to ₹32.48 crore, up 93% from the prior year. Net profit followed, rising 39% to ₹54.40 lakhs. The growth was concentrated in the final three months: Q4 revenue of ₹16.76 crore was almost three times the year-ago quarter. That quarter still posted a net loss of ₹35.37 lakhs, but only because a ₹31 lakh one-off exceptional charge and a deferred tax provision hit the books. The auditors signed off with a clean opinion. The board skipped the dividend, a standard move for a small company reinvesting its cash to service the domestic and export orders it has been winning. The results are backward-looking, but they confirm the trajectory the market already priced in through the order wins.
Questions answered
- Why did Veerhealth report a full-year profit but a Q4 loss?
- The company booked a ₹31 lakh exceptional charge and a deferred tax provision in the fourth quarter, which pushed that period to a net loss of ₹35.37 lakhs. The charge was one-off, so the full year remained profitable at ₹54.40 lakhs.
- How fast is the company growing?
- Annual revenue grew 93% year-on-year to ₹32.48 crore. Fourth-quarter revenue of ₹16.76 crore was nearly triple the ₹5.8 crore it reported in the same quarter last year.
- What did the auditors say about the results?
- The auditors issued an unmodified, or clean, opinion on the standalone financial results for the quarter and year ended March 2026.
- Why isn't Veerhealth paying a dividend?
- The board chose not to recommend a dividend for FY26 to conserve resources. This is consistent with a company reinvesting cash to fund the growth from its recent order wins.
Story so far
All notes on NIYATILEAS →- 30 May 2026 · 1:05 PM IST Veerhealth's annual revenue nearly doubles to ₹32.5 cr, but Q4 flips to a loss
- 5d ago Veerhealth Care sets date for FY26 results and dividend review